搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Arabidopsis thaliana Primary amine oxidase (At1g62810), partial CSB-YP811507DOA
CSB-EP811507DOA
CSB-BP811507DOA
CSB-MP811507DOA
CSB-EP811507DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana ABC transporter I family member 10, chloroplastic (ABCI10) CSB-YP811508DOA
CSB-EP811508DOA
CSB-BP811508DOA
CSB-MP811508DOA
CSB-EP811508DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Protein WAX2 (WAX2), partial CSB-YP811509DOA1
CSB-EP811509DOA1
CSB-BP811509DOA1
CSB-MP811509DOA1
CSB-EP811509DOA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mentha aquatica R-linalool synthase, chloroplastic, partial CSB-YP811510MHAP
CSB-EP811510MHAP
CSB-BP811510MHAP
CSB-MP811510MHAP
CSB-EP811510MHAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Probable protein phosphatase 2C 65 (Os07g0646100, LOC_Os07g45170) CSB-YP811511OFG
CSB-EP811511OFG
CSB-BP811511OFG
CSB-MP811511OFG
CSB-EP811511OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Cyclin-D1-2 (CYCD1-2) CSB-YP811512OFG
CSB-EP811512OFG
CSB-BP811512OFG
CSB-MP811512OFG
CSB-EP811512OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Exportin-T (Os07g0613300, LOC_Os07g42180), partial CSB-YP811513OFG
CSB-EP811513OFG
CSB-BP811513OFG
CSB-MP811513OFG
CSB-EP811513OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica tRNA wybutosine-synthesizing protein 2/3/4 (Os07g0515000, LOC_Os07g33100), partial CSB-YP811514OFG
CSB-EP811514OFG
CSB-BP811514OFG
CSB-MP811514OFG
CSB-EP811514OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zea mays FACT complex subunit SPT16 (SPT16), partial CSB-YP811515ZAX
CSB-EP811515ZAX
CSB-BP811515ZAX
CSB-MP811515ZAX
CSB-EP811515ZAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Serine carboxypeptidase-like 13 (SCPL13) CSB-YP811516DOA
CSB-EP811516DOA
CSB-BP811516DOA
CSB-MP811516DOA
CSB-EP811516DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica tRNA wybutosine-synthesizing protein 1 homolog (TYW1), partial CSB-YP811517OFG
CSB-EP811517OFG
CSB-BP811517OFG
CSB-MP811517OFG
CSB-EP811517OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Probable UDP-arabinose 4-epimerase 1 (UEL-1), partial CSB-YP811518OFG
CSB-EP811518OFG
CSB-BP811518OFG
CSB-MP811518OFG
CSB-EP811518OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant NADH-ubiquinone oxidoreductase chain 2 (nd2), partial CSB-YP811519CXX1
CSB-EP811519CXX1
CSB-BP811519CXX1
CSB-MP811519CXX1
CSB-EP811519CXX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cytochrome c oxidase subunit 2 (cox-2), partial CSB-YP811520CXX1
CSB-EP811520CXX1
CSB-BP811520CXX1
CSB-MP811520CXX1
CSB-EP811520CXX1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alouatta guariba ATP synthase protein 8 (MT-ATP8), partial CSB-YP811521AHAL
CSB-EP811521AHAL
CSB-BP811521AHAL
CSB-MP811521AHAL
CSB-EP811521AHAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lecanicillium muscarium Cytochrome b (cob), partial CSB-YP811522LDAN
CSB-EP811522LDAN
CSB-BP811522LDAN
CSB-MP811522LDAN
CSB-EP811522LDAN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Myotis macrodactylus Cytochrome b (MT-CYB), partial CSB-YP811523MHAQ
CSB-EP811523MHAQ
CSB-BP811523MHAQ
CSB-MP811523MHAQ
CSB-EP811523MHAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pinus palustris Maturase K (matK), partial CSB-YP811524PJAG
CSB-EP811524PJAG
CSB-BP811524PJAG
CSB-MP811524PJAG
CSB-EP811524PJAG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pinus ponderosa Maturase K (matK), partial CSB-YP811525PJAH
CSB-EP811525PJAH
CSB-BP811525PJAH
CSB-MP811525PJAH
CSB-EP811525PJAH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pisum sativum Photosystem II reaction center protein T (psbT), partial CSB-YP811526EWE
CSB-EP811526EWE
CSB-BP811526EWE
CSB-MP811526EWE
CSB-EP811526EWE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>